glp 1 and pancreatic cancer Glucagon-like peptide-1 receptor agonists risk of gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials Glucagon-like peptide-1 medicines and cancer

Inulin is a type of dietary fiber called a fructan that functions as a prebiotic, which means that it nourishes health-promoting bacteria in the body

BPC-157 and TB-500 do not compete with IGF-1 for receptor binding, making them ideal companions that address collagen synthesis, angiogenesis, and satellite cell activation without metabolic interference

At the time of its discovery, the EPR effect was considered an Achilles heel of cancer, expected to enable efficient accumulation of nanomedicines at tumor sites and thereby improve oncology treatments 42

In mice lacking SGLT1, the reduction in postprandial glucose response mediated by a single administration of metformin is attenuated, but not in mice lacking glucose transporter 2 (GLUT2)

10.1172/JCI116972 176 KangC.XieL.GunasekarS